ICHOR Vascular is a percutaneous clot retrieval system that replicates what works well in a surgical embolectomy. The ICHOR 7F and 14F systems aim to eliminate surgical and drug complications while providing a straightforward health economic benefit.

Strategic insights into C-Suite needs and issues, C Suite relationships, and strategies to change the way CROs partner with the MedTech Industry.

Euphrates Vascular ICHOR Vascular and Pulse Therapeutics) is a Medical Device company aimed at becoming the market leader in opening vascular occlusions related to vascular disease. Our early focus is in the $3.5B Limb Ischemia market with technologies that will platform into Ischemic Stroke, Interventional Cardiology, Wound Care, Dialysis, Interventional Oncology and Orthopedic markets. https://euphratesvascular.com/ "Flow Is Life"1. ICHOR is a Percutaneous Reperfusion System to treat embolic / thrombotic events. 2. Pulse MED uses iron based nanoparticles influenced by external magnetic power designed to treat and diagnose vascular conditions current technologies cannot reach.

Fundamentally change the way we do business with our clients. Moving from transactional activites towards preferred partnerships to alliance focused relationships.Develop large industry C-Suite relationships that re-invent the development and innovation process in the MedTech industry and bring corporate value to the C level P&L.Lead; via Executive in Residence (CEO), MedTech development programs through the premarket gauntlet to bring innovation to commercially ready positions - less risk, higher value proposition for the clients we represent. (See MedTech Strategist Articles)Duties include master services negotiations (MSA), letters of intent (LOI), pricing agreements and structures, grant letters (NIH), term sheets, subscription agreements, etc.June 2015 accepted the addition of Latin America expansion for NAMSA which also assumes over-arching agent support and mangement in Isreal, Australia, and South Korea.January 2016 assigned the role of Executive In Residence for a novel percutaneous embolectomy technology under MRO development at NAMSA. Acting CEO on behalf of NAMSA and clients mutual interests.

Championed P&L responsibly for sales, marketing, and new business for NAMSA’s clinical, regulatory, and consulting business unit. A leg in sales and marketing, another in clinical operations.Identified new business acquisitions (M&A targets), strategic operational partnerships, operational models, and alliance deals to boost offerings and deal making.Assess client device technologies, regulatory strategies, funding aproach, development strategies, all to poise clients for marketing adoption and long term business opportunities.Key member of the leadership team developing and driving NAMSA’s “MRO” client messaging.Restructured the business development department, functions, and strategies across the organization to improve communication and create internal and client efficiencies. 13 reports, 7 direct reports.Redefined MarComm to “MedComm”, Medical Communications (NAMSA University) which contains publications, whitepapers, educational seminars, blogs, and webinars to serve NAMSA’s market awareness needs and lead generation. Educational Department generates ~$1MM in revenue.Developed a Medical Advisor Board (MAB) framework that brings sponsor, physician, and NAMSA research capabilities together to enhance medical research and promotes new business.Primary lead on the integration team driving the 7-2012 Integra acquisition and implementation.Supported due diligence and led integration efforts for the 12-2013 Medvance acquisition and implementation.Appointed the Customer Relationship Management (CRM) implementation champion for C&C business unit.

Strategic Direction for Global Accounts.

Contributor to the direction of the PV Division by attending strategic planning meetings, regional manager meetings, and other key discussion related to Division growth and development.

Training new reps, Distributors, International Acct Executives, and Product Mangers on our business, procedures, and our devices.

Calling on Interventional Radiologists, Vascular Surgeons, Cardiology, Nursing, Admin etc. Selling minimally invasive, image guided devices and procedures. Products include, dialysis catheters, balloons, stents, peripheral catheters, infusion catheters, ports, piccs, vein lasers, wires, emolics, etc.

Hired to build a sales team as a part of a Start Up effort. AHS represented the only FDA approved line of Nutriceuticals designed to driven by a physician sales model.

Calling on ORs, ERs, Labs, and ICUs. Selling OR Tables, Surgical Lights, Ortho Fracture Tables, Stretchers and Pedi Cribs.

SIMS - Portex calling on Hospitals, Acute Care Centers, Ambulance Services, and Home Health Care Distributors.SIMS Level 1 calling on Anesthesia, Trauma, ER, Urology, ICU, and PACU with Blood and Fluid Warmers, and Trauma Infusers.